Influenza vaccine for NIH flu campaign from sanofi pasteur:1110336 [pots: 20-009219]

Ended Awarded Last action

Contract number
75N90020F00001
Awardee
Awarding agency
Obligated
$139,025

Award facts

Contract value 100% obligated
$139,025.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Swiftwater, PA 18370, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 · To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$0
Funding Only Action P00003 $5,002
Other Administrative Action P00002 · To provide for the federal excise tax $0
Exercise an Option P00001 $72,052
Original award $61,971

About this award

The National Institutes of Health Clinical Center issued a BPA call to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on April 29, 2020, with a ceiling value of $139,025.12 for influenza vaccine delivery under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). Work is performed in Swiftwater, Pennsylvania. The call required de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for September 30, 2026 closing of the period of availability for those funds. Ultimate completion was April 26, 2025. Pricing is firm fixed price.

Quick answers

Who was awarded contract 75N90020F00001?

75N90020F00001 was awarded to Sanofi Vaccines US Inc. by NIH Clinical Center (National Institutes of Health) on April 29, 2020.

How much is contract 75N90020F00001 worth?

The government has obligated $139,025 on 75N90020F00001.

Is contract 75N90020F00001 an order under another contract?

Yes. 75N90020F00001 is a BPA call under V797D50457-75N90020A00005, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75N90020F00001 competed?

The extent of competition for 75N90020F00001 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award